Shuxi Qiao
Pfizer (United States)(US)
Publications by Year
Research Areas
Nutrition and Health in Aging, Endoplasmic Reticulum Stress and Disease, Histone Deacetylase Inhibitors Research, Autophagy in Disease and Therapy, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors(2015)196 cited
- → A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity(2015)191 cited
- → GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates(2020)170 cited
- → The Tryptophan-Derived Endogenous Aryl Hydrocarbon Receptor Ligand 6-Formylindolo[3,2-b]Carbazole Is a Nanomolar UVA Photosensitizer in Epidermal Keratinocytes(2014)83 cited
- → The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death(2013)81 cited
- → The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis(2011)81 cited
- → PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis(2021)69 cited
- → Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation(2022)62 cited
- → Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes(2012)58 cited
- → REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors(2020)56 cited